Induction of IFN-γ gene expression by thioredoxin: Positive feed-back regulation of Th1 response by thioredoxin and IFN-γ

Cellular Physiology and Biochemistry

Volumn 21, Issue 1-3, 2008, Pages 215-224

  Kang, Myoung Wha ^a   Jang, Ji Young ^a   Choi, Ja Young ^a   Kim, Seol Hee ^a   Oh, Jiyoung ^a   Cho, Byoung Soo ^b   Lee, Choong Eun ^a  

^a Sungkyunkwan University   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

Author keywords

Gamma irradiation; IFN ; Oxidative stress; Positive feed back; Th1 response; Thioredoxin

Indexed keywords

ALPHA INTERFERON; BETA ACTIN; CYTOCHROME C; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; INTERLEUKIN 4; IONOMYCIN; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; STAT1 PROTEIN; THIOREDOXIN;

APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; GAMMA IRRADIATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; LEUKEMIA CELL LINE; OXIDATIVE STRESS; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH1 CELL;

EID: 38349109097     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000113763     Document Type: Article

References (42)

1. Agnello D, Lankford, CS, Bream J, Morinobu A, Gardina M, O'Shea JJ, Frucht, DM: Cytokines and transcription factors that regulate T helper cell differentiation: new players and new insights. J Clin Immunol 2003;23:147-161.
2. Murphy KM, Reiner SL: The lineage decisions on helper T cells. Nat Rev Immunol 2002;2:933-944.
3. Nembrini C, Abel B, Koph M, Marsland BJ: Strong TCR signaling TLR ligands, and cytokine redundancies ensure robust development of type 1 effector T cells. J Immunol 2006;176:7180-7188.
4. Yagi J, Arimura, Takatori H, Nakajima H, Iwamoto I, Uchiyama, T: Genetic background influences Th cell differentiation by controlling the capacity for IL-2-induced IL-4 production by naive CD4+ T cells. Int Immunol 2006;18:1681-1690.
5. Angelini G, Gadella S, Ardy M, Criolo MR, Filomeni G, Di Trapani G, Clarke F, Sitia R, Rubartelli A: Antigen presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation. Proc Natl Acad Sci USA 2002;99:1491-1496.
6. Edinger A, Thompson CB: Antigen presenting cells control T cell proliferation by regulating amino acid availability. Proc Natl Acad Sci USA 2002;99:1107-1109.
7. Eagle H, Washington C, Friedman SM: The synthesis of homocystine, cystathionine, and cystine by cultured diploid and heteroploid human cells. Proc Natl Acad Sci USA 1966;56:156-163.
8. Ueda S, Masutani H, Nakamura H, Tanaka T, Ueno M, Yodoi J: Redox control of cell death. Antioxid Redox Signal 2002;4:405-414.
9. Yodoi J, Tursz T: ADF, a growth-promoting factor derived from adult T cell leukemia and homologous to thioredoxin: involvement in lymphocyte immortalization by HTLV-I and EBV. Adv Cancer Res 1991;57:381-411.
10. Nilsson J, Soderberg O, Nilsson K, Rosen A: Thioredoxin prolongs survival of Btype chronic lymphocytic leukemia cells. Blood 2000;95:1420-1426.
11. Casagrande S, Bonetto V, Fratelli M, Gianazza E, Eberini I, Massigna T, Samona M, Chang G, Holmgren A, Ghezzi P: Glutathionylation of human thioredoxin: A possible crosstalk between glutathione and thioredoxin systems. Proc Natl Acd Sci USA 2002;99:9745-9749.
12. Nakamura H, Nakamura K, Yodoi J: Redox regulation of cellular activation. Annu Rev Immunol 1997;15:351-369.
13. Pekkari K, Avila-Cariño J, Bengtsson A, Gurunath R, Scheynius A, Holmgren A: Truncated thioredoxin (Trx80) induces production of interleukin-12 and enhances CD14 expression in human monocytes. Blood 2001;97:3184-3190.
14. Schenk H, Vogt M, Droge W, Schulze-Osthoff K: Thioredoxin as a potent costimulus of cytokine expression. J Immunol 1996;156:765-771.
15. Yoshida S, Katoh T, Tetsuka T, Uno K, Matsui N, Okamoto T: Involvement of thioredoxin in rheumatoid arthritis: its costimulatory roles in the TNF-alpha-induced production of IL-6 and IL-8 from cultured synovial fibroblasts. J Immunol 1999;163:351-358.
16. Bertini R, Howard OM, Dong HF, Oppenheim JJ, Bizzarri C, Sergi R, Caselli G, Pagliei S, Romines B, Wilshire JA, Mengozzi M, Nakamura H, Yodoi J, Pekkari K, Gurunath R, Holmgren A, Herzenberg LA, Herzenberg LA, Ghezzi P: Thioredoxin, a redox enzyme released in infection and inflammation, is a unique chemoattractant for neutrophils, monocytes, and T cells. J Exp Med 1999;189:1783-1789.
17. So EY, Park HH, Lee CE: Interferon gamma and alpha post-transcriptionally down-regulate IL-4-induced IL-4 receptor gene expression. J Immunol 2000;165:5472-5479.
18. Rho HS, Park SS, Lee CE: Gamma irradiation upregulates B cell differentiation antigen CD23 via NF-kB activation. J Biochem Mol Biol 2004;37:507-514.
19. Jang JY, Lee CE: IL-4-induced upregulation of adenine nucleotide translocase 3 and its role in T cell survival from apoptosis Cell Immunol 2006;241:14-25.
20. Kanda N, Watanabe S: Gangliosides GD1b, GT1b, and GQ1b enhance IL-2 and IFNgamma production and suppress IL-4 and IL-5 production in phytohemagglutinin-stimulated human T cells. J. Immunol 2001;166:72-80.
21. So EY, Oh JY, Jang JY, Kim JH, Lee CE: Ras/Erk pathway positively regulates Jak/Stat6 activation and IL-4 gene expression in Jurkat T cells. Mol Immunol 2007;44:3416-3426.
22. Kong KA, Jang JY, Lee CE: Identification of DC21 as a target gene counter-regulated by IL-4 and IL-12. J Biochem Mol Biol 2002;35:623-628.
23. Jang JY, Lee CE: Mitochondrial adenine nucleotide translocase 3 is regulated by IL-4 and IFN-r via STAT-dependent pathways. Cell Immunol 2003;226:11-19.
24. Murata Y, Amao M, Yoneda J, Hamuro J: Intracellular thiol redox status of macrophages directs the Th1 skewing in thioredoxin transgenic mice during aging. Mol Immunol 2001;38:747-757.
25. Sahaf B, Rosen A: Secretion of 10-kDa and 12-kDa thioredoxin species from blood monocytes and transformed leukocytes. Antioxid Redox Signal 2000;2:717-726.
26. Tanaka T, Hosoi F, Yamaguchi-Iwai Y, Nakamura H, Masutani H, Ueda S, Yodoi J: Thioredoxin-2 (TRX-2) is an essential gene regulating mitochondria-dependant apoptosis. EMBO J 2002;21:1695-1703.
27. Pekkari K, Gurunath R, Arner ESJ, Holmgren A: Truncated thioredoxin is a mitogenic cytokine for resting human peripheral blood mononuclear cells and is present in human plasma. J Biol Chem 2000;275:37474-37480.
28. Nakamura H, De Rosa SC, Yodoi J, Holmgren A: Chronic elevation of plasma thioredoxin: inhibition of chemotaxis and curtailment of life expectancy in AIDS. Proc Natl Acad Sci USA 2001;98:2688-2693.
29. del Val G, Yee BC, Lozano RM, Buchanan BB, Ermel RW, Lee YM, Frick OL: Thioredoxin treatment increases digestibility and lowers allergenicity of milk. J Allergy Clin Immunol 1999;103:690-697.
30. Darnell JE, Kerr IM, Stark GR: Jak-Stat pathways and transcriptional activation in response to IFNs and other exrtacellular signaling proteins. Science 1994;264:1415-1421.
31. Soderberg A, Sahaf B, Rosen A: Thioredoxin reductase, a redox-active selenoprotein, is secreted by normal and neoplastic cells:presence in human plasma. Cancer Res 2000;60:2281-2289.
32. Arunachalam B, Phan UT, Geuze HJ, Cresswell P: Enzymatic reduction of disulfide bonds in lysosomes: characterization of a gamma interferoninducible lysosomal thiol reductase (GILT). Proc Natl Acad Sci USA 2000;97:745-750.
33. Pekkari K, Avila-Carino J, Grunath R, Bengtsson A, Scheynius A, Holmgren A: Truncated thioredoxin(Trx80) exerts unique mitogenic cytokine effects via a mechanism independent of thiol oxidoreductase activity. FEBS Lett 2003;539:143-148.
34. Kondo N, Ishii Y, Kwon YW, Tanito M, Horita H, Nishinaka Y, Nakamura H, Yodoi J: Redox-sensing release of human thioredoxin from T lymphocytes with negative feedback loops. J Immunol 2004;172:442-448.
35. Sato N, Iwata S, Nakamura K, Hori T, Mori K, Yodoi J: Thiol-mediated redox regulation of apoptosis. Possible roles of cellular thiols other than glutathione in T cell apoptosis. J Immunol 1995;154:3194-3203.
36. Didier C, Kerblat I, Drouet C, Favier A, Beani JC, Richard MJ: Induction of thioredoxin by ultraviolet-A radiation prevents oxidative-mediated cell death in human skin fibroblasts. Free Radic Biol Med 2001;31:585-598.
37. Liu Y, Min W: Thioredoxin promotes ASK1 ubiquitination and degradation to inhibit ASK1-mediated apoptosis in a redox activity-independent manner. Circ Res 2002;90:1259-1266.
38. Matthews JR, Wakasugi N, Virelizier JL, Yodoi J, Hay RT: Thioredoxin regulates the DNA binding activity of NF-kappaB by reduction of a disulphide bond involving cysteine 62. Nucleic Acids Res 1992;20:3821-3830.
39. Makino Y, Yoshikawa N, Okamoto K, Hirota K, Yodoi J, Makino I, Tanaka H: Direct association with thioredoxin allows redox regulation of glucocorticoid receptor or function. J Biol Chem 1999;274:3182-3188.
40. Hirota K, Matsui M, Iwata S, Nishiyama A, Mori K, Yodoi J: AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc Natl Acad Sci USA 1997;94:3633-3638.
41. Kaghad M, Dessarps F, Jacquemin-Sablon H, Caput D, Fradelizi D, Wollman EE: Genomic cloning of human thioredox-inencoding gene: mapping of the transcription start point and analysis of the promoter. Gene 1994;140:273-278.
42. Nagai H, Noguchi T, Takeda K, Ichijo H: Pathophysiological roles of ASK1-MAP kinase signaling pathways. J Biochem Mol Biol 2007;40:1-6.